Mark J Wigglesworth (Mark Wigglesworth)

Years Active: 2020-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ashley J Clark, Niamh Mullooly, Dewi Safitri, Matthew Harris, Tessa de Vries, Antoinette MaassenVanDenBrink, David R Poyner, Davide Gianni, Mark J Wigglesworth, Graham Ladds
CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells. Communications biology 4 (1) (2021)
Florian David, Andrew M Davis, Michael Gossing, Martin A Hayes, Elvira Romero, Louis H Scott, Mark J Wigglesworth
A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities. SLAS discovery : advancing life sciences R & D 26 (5) (2021)
John Vincent, Marian Preston, Elizabeth Mouchet, Nicolas Laugier, Adam Corrigan, Jérôme Boulanger, Dean G Brown, Roger Clark, Mark J Wigglesworth, Andrew P Carter, Simon L Bullock
A High-Throughput Cellular Screening Assay for Small-Molecule Inhibitors and Activators of Cytoplasmic Dynein-1-Based Cargo Transport. SLAS discovery : advancing life sciences R & D 25 (9) (2020)

Mark J Wigglesworth.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Wigglesworth)